Status:

COMPLETED

Study on the Device "Gondola" for Motor Rehabilitation in Parkinson's Disease

Lead Sponsor:

IRCCS San Raffaele Roma

Conditions:

Parkinson Disease

Eligibility:

All Genders

45+ years

Phase:

NA

Brief Summary

The purpose of this research study is to evaluate safety and effectiveness of the Automated Mechanical Peripheral Stimulation (AMPS) therapy given via the Gondola™ device to improving Gait and Gait Re...

Detailed Description

The proposed project, through a randomized multicentric, placebo controlled double-blind crossover trial aimed at evaluating the effectiveness of AMPS Gondola therapy versus Sham Gondola therapy in PD...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Patients with clinically chronic and stable PD, confirmed according to the UK Parkinson's Disease Society Brain Bank Clinical Diagnosis Criteria (UKPDSBBC);
  • Age 45 and older;
  • Hoehn \& Yahr (H\&Y) stage equal or higher than 2 in ON state;
  • Ability to walk autonomously or with minimal assistance for a 10 meters' distance in OFF state;
  • Antiparkinsonian treatment at a stable and optimized daily dosage during the 4 weeks prior to the study.
  • Exclusion criteria
  • Any advanced, severe or unstable disease other than PD, which may interfere with the primary and secondary study outcome evaluations (autonomic dysfunction, diabetes, renal or hepatic failure, neoplasia, balance and gait problems of other origin).
  • Cognitive impairment with MoCA \< 18
  • Any peripheral neurological or musculoskeletal conditions that may alter balance and/or gait.
  • Severe lower limb injuries in the previous 6 months.
  • History of neurosurgery or orthopedic surgery.
  • History of epilepsy.
  • Any drug treatment not intended to treat PD that may alter cognitive and/or motor performance.
  • History of depression or other psychiatric disorders.
  • Severe obesity defined as a BMI greater than 35.

Exclusion

    Key Trial Info

    Start Date :

    December 1 2017

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    September 30 2019

    Estimated Enrollment :

    124 Patients enrolled

    Trial Details

    Trial ID

    NCT03843268

    Start Date

    December 1 2017

    End Date

    September 30 2019

    Last Update

    April 10 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    IRCCS San Raffaele

    Roma, Italy, 00163